Celldex Therapeutics | CLDX - Acreedores Comerciales

Precio De Mercado
30.94
Cambio Diario
-0.86 -2.70%
Mensual
0.39%
Anual
53.55%
Q1 Expectativa
29.97




Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 82.99M 2.3M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Northwest Biotherapeutics 27.22M 5.8M 2025-03
Pfizer USD 5.02B 142M 2025-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12